Parenteral formulation of nimodipine

Details Parenteral formulation of nimodipine Parenteral formulation of nimodipine

1991-01-15

1992-05-19

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3144

Patent

active

051149567

ABSTRACT:
A parenteral formulation comprising about

REFERENCES:
patent: 4154839 (1979-05-01), Wehinger et al.
patent: 4166855 (1979-09-01), Wehinger et al.
patent: 4256749 (1981-03-01), Horstmann et al.
Husa's Pharmaceutical Dispensing, Mack Pub. Co., Easton, Pa., (1966), pp. 400-401.
Pharmaceutical Sciences, (1980), Mack Pub. Co., Easton, Pa., p. 1467.
Chem. Abstracts, vol. 92 (1980) 220691r.

Affiliated with

Also associated with

Rating

Parenteral formulation of nimodipine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parenteral formulation of nimodipine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral formulation of nimodipine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2417640